Lanean...
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review
Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...
Gorde:
| Argitaratua izan da: | Clin Med Res |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Marshfield Clinic
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/ https://ncbi.nlm.nih.gov/pubmed/31160476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|